Ovid Therapeutics Inc. (24) | Human Resources (10)
Browse by Subcategory
Recent Contracts
-
Non-Employee Director Compensation Policy, effective May 5, 2022
(Filed With SEC on May 10, 2022)
-
Amended and Restated Executive Employment Agreement between the Company and Jeffrey Rona, effective June 2, 2021
(Filed With SEC on August 16, 2021)
-
Separation and Consulting Agreement, by and between the Company and Matthew During, dated as of March 24, 2019
(Filed With SEC on May 7, 2019)
-
Non-Employee Director Compensation Policy, effective May 6, 2021
(Filed With SEC on November 10, 2021)
-
Executive Employment Agreement between the Company and Jeff Rona, effective September 30, 2020
(Filed With SEC on March 15, 2021)
-
Executive Employment Agreement between the Company and Jason Tardio, effective October 21, 2019
(Filed With SEC on March 15, 2021)
-
Amended and Restated Executive Employment Agreement between the Company and Thomas Perone, effective January 1, 2020
(Filed With SEC on March 15, 2021)
-
Non-Employee Director Compensation Plan
(Filed With SEC on March 11, 2020)
-
Second Amended and Restated Executive Employment Agreement between the Company and Amit Rakhit, effective November 1, 2019
(Filed With SEC on March 11, 2020)
-
Third Amended and Restated Executive Employment Agreement between the Company and Tim Daly, effective December 18, 2019
(Filed With SEC on March 11, 2020)